IRIS Accounts Production v25.2.0.378 07066909 Board of Directors 1.12.23 30.11.24 30.11.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070669092023-11-30070669092024-11-30070669092023-12-012024-11-30070669092022-11-30070669092022-12-012023-11-30070669092023-11-3007066909ns15:EnglandWales2023-12-012024-11-3007066909ns14:PoundSterling2023-12-012024-11-3007066909ns10:Director12023-12-012024-11-3007066909ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3007066909ns10:SmallEntities2023-12-012024-11-3007066909ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3007066909ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3007066909ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3007066909ns10:FullAccounts2023-12-012024-11-3007066909ns10:Director22023-12-012024-11-3007066909ns10:Director32023-12-012024-11-3007066909ns10:Director42023-12-012024-11-3007066909ns10:Director52023-12-012024-11-3007066909ns10:RegisteredOffice2023-12-012024-11-3007066909ns5:CurrentFinancialInstruments2024-11-3007066909ns5:CurrentFinancialInstruments2023-11-3007066909ns5:ShareCapital2024-11-3007066909ns5:ShareCapital2023-11-3007066909ns5:RetainedEarningsAccumulatedLosses2024-11-3007066909ns5:RetainedEarningsAccumulatedLosses2023-11-3007066909ns5:FurnitureFittings2023-12-012024-11-3007066909ns5:FurnitureFittings2023-11-3007066909ns5:ComputerEquipment2023-11-3007066909ns5:ComputerEquipment2023-12-012024-11-3007066909ns5:FurnitureFittings2024-11-3007066909ns5:ComputerEquipment2024-11-3007066909ns5:FurnitureFittings2023-11-3007066909ns5:ComputerEquipment2023-11-3007066909ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3007066909ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-30
REGISTERED NUMBER: 07066909 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH NOVEMBER 2024

FOR

S.L.N. MEDICS LTD.

S.L.N. MEDICS LTD. (REGISTERED NUMBER: 07066909)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH NOVEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


S.L.N. MEDICS LTD.

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH NOVEMBER 2024







DIRECTORS: Krishna Kanth Vemulapalli
Sridevi Vemulapalli
Kaylan Vamshi Vemulapalli
Vidwat Aashrit Vemulapalli
Lakshmi Vidhatri Vemulapalli





REGISTERED OFFICE: 4a Freeman Way
Hornchurch
Essex
RM11 3PH





REGISTERED NUMBER: 07066909 (England and Wales)





ACCOUNTANTS: Clemence Hoar Cummings
Chartered Accountants
Riverside House
1-5 Como Street
Romford
Essex
RM7 7DN

S.L.N. MEDICS LTD. (REGISTERED NUMBER: 07066909)

BALANCE SHEET
30TH NOVEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 175 539

CURRENT ASSETS
Debtors 5 86,423 76,992
Cash at bank 48,150 25,874
134,573 102,866
CREDITORS
Amounts falling due within one year 6 20,103 13,311
NET CURRENT ASSETS 114,470 89,555
TOTAL ASSETS LESS CURRENT
LIABILITIES

114,645

90,094

CAPITAL AND RESERVES
Called up share capital 110 110
Retained earnings 114,535 89,984
SHAREHOLDERS' FUNDS 114,645 90,094

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th November 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29th August 2025 and were signed on its behalf by:





Krishna Kanth Vemulapalli - Director


S.L.N. MEDICS LTD. (REGISTERED NUMBER: 07066909)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH NOVEMBER 2024


1. STATUTORY INFORMATION

S.L.N. MEDICS LTD. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

S.L.N. MEDICS LTD. (REGISTERED NUMBER: 07066909)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH NOVEMBER 2024


4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st December 2023
and 30th November 2024 4,178 1,455 5,633
DEPRECIATION
At 1st December 2023 4,178 916 5,094
Charge for year - 364 364
At 30th November 2024 4,178 1,280 5,458
NET BOOK VALUE
At 30th November 2024 - 175 175
At 30th November 2023 - 539 539

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 16,214 15,730
Other debtors 70,209 61,262
86,423 76,992

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 329 26
Taxation and social security 16,932 8,126
Other creditors 2,842 5,159
20,103 13,311

7. RELATED PARTY DISCLOSURES

At the balance sheet date, £24,000 was owed by Harley Fitzrovia Health Ltd to S.L.N. Medics Ltd (2023 - £24,000).
At the balance sheet date, £34,000 was owed by Diagnostics4u Ltd to S.L.N Medics Ltd (2022 - £32,000).
At the balance sheet date, £7,000 was owed by S.L.N Homes Ltd to S.L.N Medics Ltd (2022 - Nil).

Dr K Vemulapalli is a Director and Shareholder of all Companies.